KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Payables (2017 - 2025)

Cardlytics (CDLX) has disclosed Payables for 9 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 93.22% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Dec 2025, down 93.22%, and an annual FY2025 reading of $3.4 million, down 93.22% over the prior year.
  • Payables was $3.4 million for Q4 2025 at Cardlytics, down from $49.7 million in the prior quarter.
  • Across five years, Payables topped out at $50.4 million in Q1 2025 and bottomed at $2.1 million in Q1 2023.
  • Average Payables over 5 years is $18.2 million, with a median of $4.7 million recorded in 2021.
  • Peak annual rise in Payables hit 1167.77% in 2025, while the deepest fall reached 93.22% in 2025.
  • Year by year, Payables stood at $4.6 million in 2021, then decreased by 18.49% to $3.8 million in 2022, then rose by 17.53% to $4.4 million in 2023, then soared by 1019.82% to $49.6 million in 2024, then crashed by 93.22% to $3.4 million in 2025.
  • Business Quant data shows Payables for CDLX at $3.4 million in Q4 2025, $49.7 million in Q3 2025, and $48.0 million in Q2 2025.